投资评级与目标价调整 - Piper Sandler维持Chewy“增持”评级，目标价设定为48美元，评级依据包括对宠物拥有量的担忧、公司2026年指引以及BC Partners仍持有约42%股权所带来的持续影响 [1] - Morgan Stanley维持Chewy“增持”评级，并于1月13日将目标价从48美元上调至51美元 [3] - 高盛将Chewy目标价上调至52美元，看好其长期上行潜力 [7] 财务表现与未来预期 - 公司2025年盈利更接近市场共识预期，与往年相比超预期幅度缩小，年初至今EBITDA仅超预期3%，而2024年平均超预期幅度为22% [2] - 预计公司对2026年将采取保守态度，指引销售额增长7-8%，与市场普遍预期的8%相近 [2] - 预计公司2026年EBITDA利润率将围绕6.6%的市场共识，并可能因杠杆改善而存在上行潜力 [2] 行业与公司背景 - Chewy是一家在线宠物食品及其他宠物相关产品和服务零售商，提供宠物食品、药物、零食及相关服务，旗下拥有Chewy Pharmacy、Connect with a Vet和CarePlus等宠物健康产品组合 [4] - 在互联网板块，预计2026年将与2025年主题相似，那些能从生成式人工智能或GPU技术中获得实质性正投资资本回报率的公司更可能获得市场奖励 [3]

As filed with the U.S. Securities and Exchange Commission on September 13, 2023 Registration Statement No. 333-271622 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 5 To FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SYRA HEALTH CORP. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 7361 85-4027995 (I.R.S. Employer Ide ...

As filed with the U.S. Securities and Exchange Commission on September 5, 2023 Registration Statement No. 333-271622 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 4 To FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SYRA HEALTH CORP. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 7361 85-4027995 (I.R.S. Employer Iden ...

As filed with the U.S. Securities and Exchange Commission on July 17, 2023 Registration Statement No. 333-271622 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 3 To FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SYRA HEALTH CORP. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 7361 85-4027995 (I.R.S. Employer Identifi ...

As filed with the U.S. Securities and Exchange Commission on July 6, 2023 Registration Statement No. 333-271622 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 2 To FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SYRA HEALTH CORP. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 7361 85-4027995 (I.R.S. Employer Identific ...

As filed with the U.S. Securities and Exchange Commission on June 12, 2023 Registration Statement No. 333-271622 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 1 To FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SYRA HEALTH CORP. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 7361 85-4027995 (I.R.S. Employer Identifi ...